107 related articles for article (PubMed ID: 4065022)
1. [Quantitative immunoenzyme determination of the lactoferrin and alpha-lactalbumin in the blood serum of cancer patients].
Vasil'ev MIu; Avdeev GI
Eksp Onkol; 1985; 7(5):56-60. PubMed ID: 4065022
[TBL] [Abstract][Full Text] [Related]
2. [Serum lactoferrin level in normal conditions and in pathology].
Sukharev AE; Nikolaev AA; Vasil'ev MIu
Vopr Med Khim; 1990; 36(3):81-3. PubMed ID: 2382440
[TBL] [Abstract][Full Text] [Related]
3. [Quantitative immunoenzyme determination of lactoferrin in the serum and plasma].
Merkulov AG; Shevchenko OP
Vopr Med Khim; 1989; 35(6):125-8. PubMed ID: 2697964
[TBL] [Abstract][Full Text] [Related]
4. Enzyme-linked immunosorbent assays for bovine alpha-lactalbumin and beta-lactoglobulin in serum and tissue culture media.
Mao FC; Bremel RD
J Dairy Sci; 1991 Sep; 74(9):2946-51. PubMed ID: 1779050
[TBL] [Abstract][Full Text] [Related]
5. Augmented release of human leucocyte lactoferrin (and elastase) during coagulation.
Adeyemi EO; Hodgson HJ
J Clin Lab Immunol; 1988 Sep; 27(1):1-4. PubMed ID: 3266944
[TBL] [Abstract][Full Text] [Related]
6. [Development of a two-site immunoassay using polyclonal antibodies for determination of lactoferrin in human blood].
Laktionov PP; Shevchuk NA; Naumov VA; Zhevachevskiĭ NG; Rykova EIu; Vlasov VV
Vopr Med Khim; 1999; 45(2):170-7. PubMed ID: 10378308
[TBL] [Abstract][Full Text] [Related]
7. [Levels of the C 4 component of the complement, lactoferrin and leukocytic thermostabile alpha glycoprotein during the treatment of patients with systemic rheumatic diseases].
Bareĭkene IP; Matulis AA; Shevchenko OP; Venalis AI
Revmatologiia (Mosk); 1989; (2):41-5. PubMed ID: 2678397
[TBL] [Abstract][Full Text] [Related]
8. [Value and prognostic significance of alpha-lactalbumin (ALA), lactoferrin (Lfr) and HMFG-2 in primary breast cancers. An immunohistochemical study].
Wrba F; Ritzinger E; Reiner A; Holzner JH
Pathologe; 1987 Jan; 8(1):25-30. PubMed ID: 3031642
[No Abstract] [Full Text] [Related]
9. alpha-Lactalbumin levels in human mammary tumors, sera, and mammary cell culture lines.
Schultz GS; Ebner KE
Cancer Res; 1977 Dec; 37(12):4489-92. PubMed ID: 200351
[TBL] [Abstract][Full Text] [Related]
10. Plasma lactoferrin reflects granulocyte activation via complement in burn patients.
Wolach B; Coates TD; Hugli TE; Baehner RL; Boxer LA
J Lab Clin Med; 1984 Feb; 103(2):284-93. PubMed ID: 6607301
[TBL] [Abstract][Full Text] [Related]
11. [Detection of alpha-fetoprotein in the blood serum postoperatively in cancer patients].
Vasil'ev MIu; Sergeeva NS
Vopr Onkol; 1985; 31(7):21-4. PubMed ID: 2411054
[TBL] [Abstract][Full Text] [Related]
12. [Immunohistochemistry of alpha-lactalbumin, lactoferrin and trans- ferrin receptor in invasive breast carcinomas with regard to tumor grading, estrogen receptor status and tumor staging].
Wrba F; Reiner A; Ritzinger E; Reiner G; Holzner JH
Verh Dtsch Ges Pathol; 1986; 70():247-50. PubMed ID: 3548128
[No Abstract] [Full Text] [Related]
13. [Plasma lactoferrin and the blood count of polynuclear neutrophils].
Harlé JR; Figarella C; Fossat C; Weiller PJ; Mongin M
Pathol Biol (Paris); 1984 Apr; 32(4):239-44. PubMed ID: 6718064
[TBL] [Abstract][Full Text] [Related]
14. An enzyme-linked immunoassay (ELISA) for measurement of lactoferrin.
Hetherington SV; Spitznagel JK; Quie PG
J Immunol Methods; 1983 Dec; 65(1-2):183-90. PubMed ID: 6317755
[TBL] [Abstract][Full Text] [Related]
15. [Determination of plasma lactoferrin by the "double sandwich" immunoenzymatic method in heterogeneous phase].
Monnard C; Vernet M
Pathol Biol (Paris); 1988 Sep; 36(7):941-4. PubMed ID: 3059281
[TBL] [Abstract][Full Text] [Related]
16. Plasma lactoferrin measured by an enzyme-linked immunosorbent assay (ELISA). Measurements on adult and infant plasma.
Kolstø Otnaess AB; Meberg A; Sande HA
Scand J Haematol; 1983 Sep; 31(3):235-40. PubMed ID: 6879106
[TBL] [Abstract][Full Text] [Related]
17. Nonspecific cross-reacting antigen 50/90 is elevated in patients with breast, lung, and colon cancer.
Allard WJ; Neaman IE; Elting JJ; Barnett TR; Yoshimura H; Fritsche HA; Yeung KK
Cancer Res; 1994 Mar; 54(5):1227-34. PubMed ID: 8118811
[TBL] [Abstract][Full Text] [Related]
18. Human kallikrein 10 ELISA development and validation in breast cancer sera.
Ewan King L; Li X; Cheikh Saad Bouh K; Pedneault M; Chu CW
Clin Biochem; 2007 Sep; 40(13-14):1057-62. PubMed ID: 17585892
[TBL] [Abstract][Full Text] [Related]
19. Quantitation of TIMP-1 in plasma of healthy blood donors and patients with advanced cancer.
Holten-Andersen MN; Murphy G; Nielsen HJ; Pedersen AN; Christensen IJ; Høyer-Hansen G; Brünner N; Stephens RW
Br J Cancer; 1999 May; 80(3-4):495-503. PubMed ID: 10408859
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of soluble urokinase plasminogen activator receptor in serum and cytosol of tumor tissue from patients with primary breast cancer.
Riisbro R; Christensen IJ; Piironen T; Greenall M; Larsen B; Stephens RW; Han C; Høyer-Hansen G; Smith K; Brünner N; Harris AL
Clin Cancer Res; 2002 May; 8(5):1132-41. PubMed ID: 12006529
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
